This inventor holds 1 USPTO granted patent. Top assignee: Snu Rdb Foundation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Seon Joo Park: Innovator in Biosensor Technology
Introduction
Seon Joo Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biosensor technology, particularly in the diagnosis of cancers. His innovative approach combines advanced materials with cutting-edge techniques to enhance the sensitivity and performance of biosensors.
Latest Patents
Seon Joo Park holds a patent for a "Method for fabricating novel high-performance field-effect transistor biosensor based on conductive polymer nanomaterials functionalized with anti-VEGF adapter." This patent discloses a method for creating a high-performance field-effect transistor biosensor that utilizes micro conductive polymer nanomaterials functionalized with anti-VEGF aptamer. The biosensor is designed for diagnosing cancers by targeting Vascular Endothelial Growth Factor (VEGF), which plays a crucial role in tumor growth and development.
Career Highlights
Seon Joo Park is associated with the SNU RDB Foundation, where he continues to advance research in biosensor technology. His work focuses on developing high-sensitivity biosensors that can significantly improve cancer diagnostics. His innovative methods and dedication to research have positioned him as a key figure in the field.
Collaborations
Seon Joo Park collaborates with notable colleagues, including Jyong S Jang and Oh Seok Kwon. These collaborations enhance the research and development efforts at the SNU RDB Foundation, fostering an environment of innovation and discovery.
Conclusion
Seon Joo Park's contributions to biosensor technology exemplify the impact of innovative research in medical diagnostics. His patented methods and collaborative efforts continue to pave the way for advancements in cancer detection and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
